EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   6.2.1.45 | Abortion, Spontaneous |
16738225 |
Proteomic analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss. |
unassigned |
0 |
| 6.2.1.45 | Adenocarcinoma |
17217624 |
Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma. |
causal interaction |
1 |
| 6.2.1.45 | Adenocarcinoma |
31715067 |
Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma. |
causal interaction |
4 |
| 6.2.1.45 | Adenocarcinoma |
31715067 |
Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma. |
diagnostic usage |
4 |
| 6.2.1.45 | Adenocarcinoma |
11948124 |
Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. |
diagnostic usage |
3 |
| 6.2.1.45 | Adenocarcinoma |
16160695 |
Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia. |
diagnostic usage |
3 |
| 6.2.1.45 | Adenocarcinoma |
17217624 |
Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma. |
therapeutic application |
1 |
| 6.2.1.45 | Adenocarcinoma |
31715067 |
Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma. |
therapeutic application |
4 |
| 6.2.1.45 | Adenocarcinoma |
17217624 |
Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma. |
ongoing research |
4 |
| 6.2.1.45 | Adenocarcinoma |
31715067 |
Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma. |
ongoing research |
3 |
